Chapel Hill, North Carolina (NC) Commercial Medical Research Companies

Featured companies
Achelios Therapeutics LLC
6340 Quadrangle Drive # 120
Chapel Hill NC 27517
(919) 354-6233
Carolyn Bell Consulting
101 Oxford Hills Place
Chapel Hill NC 27514
(919) 929-4112
Channing J Der PhD
101 Fieldstone Court
Chapel Hill NC 27514
(919) 966-5634
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Eric A Finkelstein
104 Parkridge Avenue
Chapel Hill NC 27517
Ernest N Kraybill Md
317 Crolina Meadows Villa
Chapel Hill NC 27517
Global Biopharmaceuticals Corporation
115 Stratford Drive
Chapel Hill NC 27516
(919) 619-7227
Joseph Pagano
Unc Lnbrger Cancer Cneter
Chapel Hill NC 27599
(919) 966-5907
Mcleod Pharma Ltd Inc
408 Ironwoods Drive
Chapel Hill NC 27516
Pracs Institute Ltd
307 Helmsdale Drive
Chapel Hill NC 27517
Robert Wood Johnson Clinical Scholars Program
5034 Old Clinic Building
Chapel Hill NC 27599
(919) 966-1274
Sylvia Lichtenberger
43 Bloomsbury Court
Chapel Hill NC 27517
(919) 489-7807
University Of North Carolina At Chapel Hill
105 Mason Farm Road Room 8109
Chapel Hill NC 27599
(919) 966-4068
Whereorg has 12 results under Commercial Medical Research Companies in Chapel Hill, NC.

Other locations for category Commercial Medical Research


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020